Parexel International Overview

  • Year Founded
  • 1982

Year Founded

  • Status
  • Private

  • Employees
  • 21,000

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 19

  • Investments
  • 27

Parexel International General Information

Description

Provider of biopharmaceutical services intended to aid in scientific discoveries and new treatments. The company offers a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology, and medical device industries, thereby helping them in drug development, commercialization continuum, clinical trials management, and reimbursement.

Contact Information

Website
www.parexel.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 2520 Meridian Parkway
  • Durham, NC 27713
  • United States
+1 (919)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • 2520 Meridian Parkway
  • Durham, NC 27713
  • United States
+1 (919)

Parexel International Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Parexel International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Parexel International‘s full profile, request access.

Request a free trial

Parexel International Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of biopharmaceutical services intended to aid in scientific discoveries and new treatments. The company offers
Other Pharmaceuticals and Biotechnology
Durham, NC
21,000 As of 2024

Verona, Italy
 

Morrisville, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Parexel International Competitors (27)

One of Parexel International’s 27 competitors is Cromsource, a Corporate Backed or Acquired company based in Verona, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cromsource Corporate Backed or Acquired Verona, Italy
Syneos Health Private Equity-Backed Morrisville, NC
Aragen Life Sciences Private Equity-Backed Hyderabad, India
CTI Clinical Trial and Consulting Private Equity-Backed Covington, KY
Covance Clinical Research Corporation
You’re viewing 5 of 27 competitors. Get the full list »

Parexel International Patents

Parexel International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200293712-A1 Methods, apparatus and systems for annotation of text documents Active 11-Mar-2019
US-11263391-B2 Methods, apparatus and systems for annotation of text documents Active 11-Mar-2019
US-20220253594-A1 Methods, apparatus and systems for annotation of text documents Active 11-Mar-2019
EP-3938931-A4 Methods, apparatus and systems for annotation of text documents Pending 11-Mar-2019
US-12014135-B2 Methods, apparatus and systems for annotation of text documents Active 11-Mar-2019 G06F40/169
To view Parexel International’s complete patent history, request access »

Parexel International Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Parexel International Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Parexel International‘s full profile, request access.

Request a free trial

Parexel International Investments & Acquisitions (27)

Parexel International’s most recent deal was a Buyout/LBO with Roam Analytics. The deal was made on 22-Sep-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Roam Analytics 22-Sep-2020 Buyout/LBO Enterprise Systems (Healthcare)
Model Answers 20-Feb-2020 Buyout/LBO Consulting Services (B2B)
The Medical Affairs Company 01-Mar-2017 Merger/Acquisition Other Healthcare Services
ExecuPharm 03-Oct-2016 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Health Advances 10-Feb-2016 Merger/Acquisition Consulting Services (B2B)
You’re viewing 5 of 27 investments and acquisitions. Get the full list »

Parexel International Exits (5)

Parexel International’s most recent exit was on 22-Aug-2005 from Perceptive (Healthcare). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Perceptive (Healthcare) 22-Aug-2005 Completed
PHT 09-Jul-2001 Completed
  • 10 buyers
Farmovs 16-Oct-2000 Completed
Synexel Research International 01-Jan-1999 Completed
Perceptive (Healthcare) Merger/Acquisition Completed
To view Parexel International’s complete exits history, request access »

Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Roam Analytics San Mateo, CA 2013
Health Advances Newton, MA 1992

Parexel International FAQs

  • When was Parexel International founded?

    Parexel International was founded in 1982.

  • Where is Parexel International headquartered?

    Parexel International is headquartered in Durham, NC.

  • What is the size of Parexel International?

    Parexel International has 21,000 total employees.

  • What industry is Parexel International in?

    Parexel International’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Parexel International a private or public company?

    Parexel International is a Private company.

  • What is Parexel International’s current revenue?

    The current revenue for Parexel International is .

  • How much funding has Parexel International raised over time?

    Parexel International has raised $3.86B.

  • Who are Parexel International’s investors?

    EQT and Goldman Sachs Asset Management have invested in Parexel International.

  • Who are Parexel International’s competitors?

    Cromsource, Syneos Health, Aragen Life Sciences, CTI Clinical Trial and Consulting, and Covance Clinical Research are some of the 27 competitors of Parexel International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »